[go: up one dir, main page]

EA200101117A1 - Трициклические анальгетики - Google Patents

Трициклические анальгетики

Info

Publication number
EA200101117A1
EA200101117A1 EA200101117A EA200101117A EA200101117A1 EA 200101117 A1 EA200101117 A1 EA 200101117A1 EA 200101117 A EA200101117 A EA 200101117A EA 200101117 A EA200101117 A EA 200101117A EA 200101117 A1 EA200101117 A1 EA 200101117A1
Authority
EA
Eurasian Patent Office
Prior art keywords
hydrogen
alkyl
cycloalkyl
chch
alkenyl
Prior art date
Application number
EA200101117A
Other languages
English (en)
Russian (ru)
Inventor
Алейн Калвет
Анри Жакобелли
Жоселин Пюо
Франсуа Ж. Роман
Жак Амон
Агнесса Груэль
Original Assignee
Уорнер-Ламберт Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Уорнер-Ламберт Компани filed Critical Уорнер-Ламберт Компани
Publication of EA200101117A1 publication Critical patent/EA200101117A1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20Spiro-condensed ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
EA200101117A 1999-06-07 2000-06-07 Трициклические анальгетики EA200101117A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13786899P 1999-06-07 1999-06-07
PCT/EP2000/005783 WO2000075116A2 (en) 1999-06-07 2000-06-07 Tricyclic analgesics

Publications (1)

Publication Number Publication Date
EA200101117A1 true EA200101117A1 (ru) 2002-06-27

Family

ID=22479397

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200101117A EA200101117A1 (ru) 1999-06-07 2000-06-07 Трициклические анальгетики

Country Status (21)

Country Link
EP (1) EP1235808A2 (is)
JP (1) JP2003513006A (is)
KR (1) KR20020010923A (is)
CN (1) CN1635998A (is)
AP (1) AP2001002356A0 (is)
AU (1) AU6428400A (is)
BG (1) BG106162A (is)
BR (1) BR0011427A (is)
CA (1) CA2376076A1 (is)
EA (1) EA200101117A1 (is)
HR (1) HRP20010913A2 (is)
HU (1) HUP0203317A2 (is)
IL (1) IL146755A0 (is)
IS (1) IS6175A (is)
MA (1) MA26795A1 (is)
MX (1) MXPA01012694A (is)
NO (1) NO20015966D0 (is)
PL (1) PL357340A1 (is)
SK (1) SK17512001A3 (is)
TR (1) TR200103531T2 (is)
WO (1) WO2000075116A2 (is)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
FR2915099B1 (fr) * 2007-04-19 2009-06-05 Sanofi Aventis Sa Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes craniens
AR085893A1 (es) * 2011-02-02 2013-11-06 Vertex Pharma Pirrolopirazina-amidas de piperidina espirociclica como moduladores de los canales ionicos
GB201416346D0 (en) * 2014-09-16 2014-10-29 Shire Internat Gmbh Spirocyclic derivatives
CN115872873B (zh) * 2022-12-29 2024-11-29 上海泰坦科技股份有限公司 一种双(2-溴乙基)胺氢溴酸盐的重结晶纯化方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8917069D0 (en) * 1989-07-26 1989-09-13 Merck Sharp & Dohme Therapeutic agents
IL96507A0 (en) * 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
WO1994017045A1 (en) * 1993-01-28 1994-08-04 Merck & Co., Inc. Spiro-substituted azacycles as tachykinin receptor antagonists
US5439914A (en) * 1994-02-18 1995-08-08 Merck & Co., Inc. Spirocycles
AU5604998A (en) * 1996-12-13 1998-07-03 Merck & Co., Inc. Spiro-substituted azacycles as modulators of chemokine receptor activity
US6013644A (en) * 1997-12-12 2000-01-11 Merck & Co., Inc. Spiro-substituted azacycles as modulators of chemokine receptor activity

Also Published As

Publication number Publication date
PL357340A1 (en) 2004-07-26
NO20015966L (no) 2001-12-06
MXPA01012694A (es) 2003-10-15
HRP20010913A2 (en) 2003-04-30
KR20020010923A (ko) 2002-02-06
EP1235808A2 (en) 2002-09-04
WO2000075116A2 (en) 2000-12-14
IS6175A (is) 2001-11-23
MA26795A1 (fr) 2004-12-20
BG106162A (bg) 2002-05-31
CA2376076A1 (en) 2000-12-14
CN1635998A (zh) 2005-07-06
JP2003513006A (ja) 2003-04-08
NO20015966D0 (no) 2001-12-06
TR200103531T2 (tr) 2002-06-21
AP2001002356A0 (en) 2001-12-31
IL146755A0 (en) 2002-07-25
SK17512001A3 (sk) 2002-11-06
HUP0203317A2 (hu) 2003-02-28
WO2000075116A3 (en) 2002-07-04
BR0011427A (pt) 2002-03-26
AU6428400A (en) 2000-12-28

Similar Documents

Publication Publication Date Title
DE69527072D1 (de) Endothelin antagoniste
DK0663912T3 (da) Heterocykliske etherforbindelser til forstærkning af den kognitive funktion
DK0887344T3 (da) Quinoliner og quinazoliner, som er nyttige ved terapi
NO883487D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
DK0842661T3 (da) Anvendelse af estrogenagonister og -antagonister til fremstilling af et lægemiddel til behandling af atherosclerose, uafhængigt af lipidsænkning
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
PT98114A (pt) Processo para a prparacao de 1-indolilalquil-4-(alcoxipirimidinil)piperazinas e de composicoes farmaceuticas que as contem
NO305174B1 (no) Heterocykliske forbindelser
DE69309454D1 (de) Pyridincarboximidamide und deren anwendung
ATE161268T1 (de) Androstenone
DE69833797D1 (de) Substituierte 2-benzylamino-2-phenyl-acetamidverbindungen
EA200101117A1 (ru) Трициклические анальгетики
DK0769296T3 (da) Anvendelse af et natrium- eller lysiniumsalt af crotonsyreamidderivater til fremstilling af et lægemiddel til behandling af cancer
EA199800308A1 (ru) Фенилуксусные кислоты, способ их получения и содержащие их средства
FI962768A0 (fi) N-(2-ftaali-imidoetyyli)substituoituja transpiperidiini-2,5-dikarboksylaatteja
YU165791A (sh) Postupak za pripremanje derivata 8-hlorohinolona
BR1100967A (pt) Composto, e, composição farmacêutica
DE3779813D1 (en) 1,4-dihydropyridinderivate.
DK1049672T3 (da) Azetidincarboxamid-derivater til behandling af CNS-lidelser
MY133207A (en) Substituted benzolactam compaunds
DK1049670T3 (da) Azetidincarboxamidderivater til behandling af CNS-lidelser
DK0784973T3 (da) Quinoxalinderivater til behandling af tinnitus
EA199800931A1 (ru) Способ получения ингибиторов фосфодиэстеразы iv
ATE128978T1 (de) N,n',n'-trisubstituierte 5-bisaminomethylen-1,3- dioxan-4,6-dione als acyl-coa: cholesterol- acyltransferasehemmer.
BG96022A (bg) 2-(2'метил-3',4'-тризаместени бензол)-1,3- циклохександиони, метод за борба срещу нежелана растителност и хербициден състав, използващ тези съединения